article thumbnail

JPMorgan Establishes Life Sciences Private Equity Division

HIT Consultant

Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. – The Life Sciences Private Capital team will sit within J.P. . – The Life Sciences Private Capital team will sit within J.P. Anya Schiess.

article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Key Trends and Market Summary. from $34.61

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

United Therapeutics to Acquire Miromatrix Medical for $91M

HIT Consultant

Miromatrix Background Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that includes four ongoing registration-phase studies.

article thumbnail

Verana Health Raises $150M to Expand Real-World Data Network

HIT Consultant

Empowering Physicians & Life Science Companies. In October 2021, Verana Health launched its VeraQ™ population health data engine, which is clinician-directed and enhanced by AI to securely power a data integrity feedback loop of nearly a half-billion, de-identified healthcare encounters. Strategic Partners. Expansion Plans.

article thumbnail

How are drugs developed and financed? An overview

Healthcare ECONOMIST

Biotechnology companies (biotech) or small/medium-sized biopharmaceutical companies (SMEs) are most active in drug discovery, preclinical development and early-stage clinical development. About two-thirds comes from private sector life sciences companies. The paper also lists 7 different archetypes for drug development.

article thumbnail

Q3 2023 Digital Health Funding Stalls at $2.5B

HIT Consultant

Funding Focused on Disease Treatment, Value Based Care: Funding has shifted away from pandemic-related areas like on-demand healthcare and life science R&D catalysts, which were prominent in 2021 and 2022.

article thumbnail

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

HIT Consultant

Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, and cancer, and advance research in tissue engineering and regenerative medicine.